Drug interactions
Erdafitinib + Irinotecan
Severity: Moderate
Erdafitinib and Irinotecan: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Erdafitinib inhibits P-glycoprotein, and irinotecan is a P-gp substrate. Exposure could increase, raising toxicity risk.
What this interaction means in plain words
Erdafitinib and Irinotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Erdafitinib belongs to Oncology; Irinotecan belongs to Oncology.
Why it happens
P-gp inhibition reduces efflux of irinotecan and SN-38.
What to do
Monitor for diarrhea and neutropenia; dosing irinotecan at least 6 hours apart from erdafitinib is suggested by labeling for narrow therapeutic index P-gp substrates.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Erdafitinib and Irinotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Irinotecan
- Clozapine + Irinotecan Contraindicated
- Irinotecan + Sacituzumab govitecan Contraindicated
- Adenovirus types 4 and 7 live + Irinotecan Major
- Apalutamide + Irinotecan Major
- Atazanavir + Irinotecan Major
- Carbamazepine + Irinotecan Major
Other interactions of Erdafitinib
Frequently asked questions
Can I take Erdafitinib with Irinotecan?
MediHelp rates the interaction as moderate. Erdafitinib and Irinotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib inhibits P-glycoprotein, and irinotecan is a P-gp substrate. Exposure could increase, raising toxicity risk.
How serious is the interaction between Erdafitinib and Irinotecan?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for diarrhea and neutropenia; dosing irinotecan at least 6 hours apart from erdafitinib is suggested by labeling for narrow therapeutic index P-gp substrates.
What other medicines interact with Irinotecan?
MediHelp also lists interactions of Irinotecan with, for example, Clozapine, Sacituzumab govitecan, Adenovirus types 4 and 7 live. The full list is on the Irinotecan page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
